Advertisement

Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81

News > All

Total search results: 11802 | Ordered by Date (descending)
1 2 3 ... 117 118 119  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Enthera S.r.l.. (7/28/20). "Press Release: Enthera Pharmaceuticals Raises €28 Million in Series A Financing to Advance Restorative Therapy for Type 1 Diabetes and Inflammatory Bowel Disease". Milan. 2020-07-28
Abzena Ltd.. (7/28/20). "Press Release: Abzena Receives Growth Capital Investment from Newly Launched Biospring Partners". Cambridge, Bristol, PA & San Diego, CA. 2020-07-28
BioNTech SE. (7/27/20). "Press Release: Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study". New York, NY & Mainz. 2020-07-27
BioNTech SE. (7/27/20). "Press Release: BioNTech Announces Closing of $512 Million Underwritten Offering of American Depositary Shares". Mainz. 2020-07-27
iTeos Therapeutics Inc.. (7/23/20). "Press Release: iTeos Therapeutics Announces Pricing of Initial Public Offering". Cambridge, MA & Gosselies. 2020-07-23
BioNTech SE. (7/22/20). "Press Release: BioNTech Announces Pricing of Upsized Underwritten Offering and Terms of Rights Offering". Mainz. 2020-07-22
Bayer AG. (7/22/20). "Press Release: Vesigen Therapeutics Launches with USD 28.5 Million Series A Investment Led by Leaps by Bayer and Morningside Ventures". Cambridge, MA & Berlin. 2020-07-22
BioNTech SE. (7/22/20). "Press Release: Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. 2020-07-22
Citryll B.V.. (7/21/20). "Press Release: Industry Veterans Paul Peter Tak and Eric Meldrum Join Citryll’s Board". Oss. 2020-07-21
Apollo Therapeutics Fund. (7/21/20). "Press Release: UCLB and Apollo Therapeutics Secure First Out-licensing Deal to Deerfield, a Leading U.S. Healthcare Investment Firm". London & New York, NY. 2020-07-21
BioNTech SE. (7/21/20). "Press Release: Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data". Mainz & New York, NY. 2020-07-21
BioNTech SE. (7/21/20). "Press Release: BioNTech Announces Proposed Public Offerings". Mainz. 2020-07-21
BioNTech SE. (7/20/20). "Press Release: Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. 2020-07-20
Qiagen N.V.. (7/16/20). "Press Release: Thermo Fisher Scientific and Qiagen N.V. Agree on Amended Terms to Acquisition Agreement". Waltham, MA & Venlo. 2020-07-16
[iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. 2020-07-15
Waters Corporation. (7/15/20). "Press Release: Waters Corporation Names Udit Batra President and Chief Executive Officer. Announces Preliminary Second Quarter 2020 Sales". Milford, MA. 2020-07-15
Reapplix A/S. (7/14/20). "Press Release: Reapplix Receives New Reimbursement Coding and Completes USD 22.6m Equity Financing to Drive US Commercialization". 2020-07-14
Illumina, Inc.. (7/14/20). "Press Release: Illumina Acquires Enancio’s Compression Software. Reduces Genomic Data Storage and Transfer Costs Associated with the Data Deluge". 2020-07-14
Inflazome Ltd.. (7/14/20). "Press Release: FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)". Dublin, Cambridge & Brisbane. 2020-07-14
MorphoSys AG. (7/14/20). "Press Release: MorphoSys' Licensee Janssen Announces Approval of Tremfya (Guselkumab) by U.S. FDA for Treatment of Adults with Active Psoriatic Arthritis". Planegg. 2020-07-14
Roche. (7/14/20). "Press Release: Roche Collaborates with Blueprint Medicines to Bring a New Treatment to People with RET-altered Cancers". Basel. 2020-07-14
BioNTech SE. (7/13/20). "Press Release: Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2". New York, NY & Mainz. 2020-07-13
Spirea Ltd.. (7/13/20). "Press Release: Spirea Completes Seed Funding Round to Develop the Next Generation of Antibody Drug Conjugate Therapeutics". Cambridge. 2020-07-13
Merck KGaA. (7/13/20). "Press Release: Changes in Merck Executive Board. Belén Garijo appointed Vice Chairman of the Executive Board and Deputy CEO – Udit Batra Leaves". Darmstadt. 2020-07-13
Eir Ventures. (7/10/20). "Press Release: New Nordic Life Science Venture Fund, Eir Ventures, Launched to Leverage the Untapped Potential of Health Care Innovation". Stockholm & Copenhagen. 2020-07-10
Nkarta Inc.. (7/10/20). "Press Release: Nkarta Announces Pricing of Initial Public Offering". South San Francisco, CA. 2020-07-10
Blackstone. (7/9/20). "Press Release: Blackstone Announces $4.6 Billion Final Close of Life Sciences Fund". New York, NY. 2020-07-09
Kymera Therapeutics Inc.. (7/9/20). "Press Release: Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Advance Novel Protein Degrader Therapies to Patients". Cambridge, MA. 2020-07-09
Novo Holdings A/S. (7/9/20). "Press Release: Major Danish Contribution to Billion-dollar Global Initiative to Combat Antimicrobial resistance". Copenhagen. 2020-07-09
Forbion Capital Partners. (7/9/20). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund at EUR 185 million (USD 208 million)". Naarden & Munich. 2020-07-09
MLM Medical Labs GmbH. (7/8/20). "Press Release: MLM Medical Labs Expands to the US and Nominates Thomas Wollman as Member of the Board". Düsseldorf. 2020-07-08
Foghorn Therapeutics Inc.. (7/8/20). "Press Release: Foghorn Therapeutics Announces Collaboration with Merck to Discover and Develop Novel Oncology Therapeutics Against Transcription Factor Target". Cambridge, MA. 2020-07-08
VelosBio Inc.. (7/8/20). "Press Release: VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology". 2020-07-08
Editas Medicine, Inc.. (7/7/20). "Press Release: Editas Medicine and Azzur Group Announce a Multi-year Agreement for EDIT-301 and EDIT-201 Manufacturing". Cambridge, MA & Waltham, MA. 2020-07-07
Debiopharm International SA. (7/7/20). "Press Release: Nucleai Secured $6.5m Series-A Initial Closing Led by Debiopharm to Advance Ai-Powered Precision Oncology Platform". Tel Aviv & Lausanne. 2020-07-07
CVRx, Inc.. (7/7/20). "Press Release: CVRx Raises $50 Million in New Equity Financing. Offering Will Support US Commercialization of Barostem Neo". Minneapolis, MN. 2020-07-07
Mission Therapeutics Ltd.. (7/6/20). "Press Release: Mission Raises $15m and Expands its Relationship with Pfizer". Cambridge. 2020-07-06
Idorsia Ltd.. (7/6/20). "Press Release: Idorsia Announces Positive Results in the Second Phase 3 Study of Daridorexant". Allschwil. 2020-07-06
S-Biomedic N.V.. (7/2/20). "Press Release: S-Biomedic Is Gearing Up for Significant Growth and Has Appointed a New CCO". Beerse. 2020-07-02
Paion AG. (7/2/20). "Press Release: Paion Announces U.S. FDA Approval of Remimazolam (Byfavo) for the Induction and Maintenance of Procedural Sedation". Aachen. 2020-07-02
Immatics N.V.. (7/2/20). "Press Release: Immatics Announces Completion of Business Combination and Listing on NASDAQ". Houston, TX & Tübingen. 2020-07-02
BioNTech SE. (7/1/20). "Press Release: Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. 2020-07-01
Annexon, Inc.. (7/1/20). "Press Release: Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics". South San Francisco, CA. 2020-07-01
Merck KGaA. (7/1/20). "Press Release: Merck Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition". Darmstadt. 2020-07-01
CRISPR Therapeutics AG. (6/30/20). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA. 2020-06-30
Freeline Therapeutics Ltd.. (6/30/20). "Press Release: Freeline Closes $120 Million Series C Financing Round". London. 2020-06-30
CRISPR Therapeutics AG. (6/29/20). "Press Release: CRISPR Therapeutics Announces Proposed Offering of Common Shares". Zug & Cambridge, MA. 2020-06-29
BioNTech SE. (6/29/20). "Press Release: BioNTech to Raise USD 250 Million in Private Placement". Mainz. 2020-06-29
Editas Medicine, Inc.. (6/26/20). "Press Release: Editas Medicine Announces Closing of Offering of Common Stock and Full Exercise by Underwriter of Option to Purchase Additional Shares". Cambridge, MA. 2020-06-26
CRISPR Therapeutics AG. (6/25/20). "Press Release: CRISPR Therapeutics Announces the Build-Out of New Cell Therapy Manufacturing Facility". Zug & Cambridge, MA. 2020-06-25
Enterome S.A.. (6/25/20). "Press Release: Enterome Completes €46.3 Million ($52.6 Million) Financing to Progress the Clinical Development of Its Therapeutic Pipeline". Paris & Cambridge, MA. 2020-06-25
PDC*line Pharma S.A.. (6/25/20). "Press Release: PDC*line Pharma Welcomes Dr. Mondher Mahjoubi as Chairman of Its Board of Directors". Liège & Grenoble. 2020-06-25
Uniqure N.V.. (6/24/20). "Press Release: Uniqure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy". Lexington, MA & Amsterdam. 2020-06-24
BioGeneration Ventures B.V.. (6/24/20). "Press Release: BioGeneration Ventures Closes BGV IV Fund at €105 Million". Naarden. 2020-06-24
Qiagen N.V.. (6/23/20). "Press Release: Qiagen Provides Information on Potential Capital Gain from Its Minority Investment in ArcherDX". Venlo. 2020-06-23
Editas Medicine, Inc.. (6/23/20). "Press Release: Editas Medicine Announces Pricing of Offering of Common Stock". Cambridge, MA. 2020-06-23
Editas Medicine, Inc.. (6/23/20). "Press Release: Editas Medicine Announces Offering of Common Stock". Cambridge, MA. 2020-06-23
Scenic Biotech B.V.. (6/23/20). "Press Release: Scenic Biotech Awarded €3.1 Million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program". Amsterdam. 2020-06-23
ArcherDX, Inc.. (6/22/20). "Press Release: Invitae and ArcherDX to Create a Global Leader in Comprehensive Cancer Genetics and Precision Oncology". San Francisco, CA & Boulder, CA. 2020-06-22
Epidarex Capital. (6/22/20). "Press Release: Epidarex Capital Closes New £102 Million UK Venture Fund to Build Successful Life Science Companies". Edinburgh. 2020-06-22
Scienion AG. (6/22/20). "Press Release: Accurate Spike-in of Circulating Tumor Cells into Blood Samples is Essential for Reliable Analysis in Oncology Applications". Berlin, Lyon & Seattle, WA. 2020-06-22
Valneva S.E.. (6/18/20). "Press Release: Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership". Saint-Herblain. 2020-06-18
Kaia Health Software GmbH. (6/18/20). "Press Release: Kaia Health Closes $26 Million Series B Financing Round". New York, NY & Munich. 2020-06-18
Orca BioSystems, Inc.. (6/17/20). "Press Release: Orca Bio Emerges With Nearly $300 Million to Transform Allogeneic Cell Therapy". Menlo Park, CA. 2020-06-17
Illumina, Inc.. (6/17/20). "Press Release: Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale". San Diego, CA. 2020-06-17
Rentschler Biopharma SE. (6/17/20). "Press Release: Rentschler Biopharma SE Appoints Alexander Dettmer as Chief Financial Officer". Laupheim & Milford, MA. 2020-06-17
Uniqure N.V.. (6/17/20). "Press Release: Uniqure Announces the Appointment of Leonard E. Post, Ph.D. to Its Board of Directors". Lexington, MA & Amsterdam. 2020-06-17
Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren. 2020-06-17
Yumab GmbH. (6/16/20). "Press Release: Corat Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program". Braunschweig. 2020-06-16
eTheRNA Immunotherapeutics N.V.. (6/16/20). "Press Release: eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept". Niel. 2020-06-16
GlaxoSmithKline plc. (6/16/20). "Press Release: Ideaya and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology". South San Francisco, CA & London. 2020-06-16
DiogenX. (6/16/20). "Press Release: DiogenX Raises €4.5M in Seed Financing from Advent France Biotechnology, Boehringer Ingelheim Venture Fund and JDRF T1D Fund". Marseille. 2020-06-16
Royalty Pharma plc. (6/15/20). "Press Release: Royalty Pharma Announces Pricing of Initial Public Offering". New York, NY. 2020-06-15
Bit Bio Ltd.. (6/13/20). "Press Release: Bit Bio Secures $41.5m of Funding from Top Life Sciences Investors". Cambridge. 2020-06-13
Editas Medicine, Inc.. (6/12/20). "Press Release: Editas Medicine Presents Pre-Clinical Data from a Study of EDIT-301 with Sickle Patient Cells for the Potential Treatment of Sickle Cell Disease". Cambridge, MA. 2020-06-12
Foundation Medicine, Inc.. (6/12/20). "Press Release: Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care". Cambridge, MA. 2020-06-12
Bavarian Nordic A/S. (6/12/20). "Press Release: Bavarian Nordic to Manufacture Additional Ebola Vaccines for Janssen". Copenhagen. 2020-06-12
Novo Nordisk A/S. (6/11/20). "Press Release: Novo Nordisk to Acquire Corvidia Therapeutics and Expand Presence in Cardiovascular Disease". Bagsvaerd. 2020-06-11
Affimed N.V.. (6/11/20). "Press Release: Affimed Announces Appointment of Angus Smith as Chief Financial Officer". Heidelberg. 2020-06-11
Egle Therapeutics S.A.S.. (6/11/20). "Press Release: Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda to Uncover Novel Tumor-specific Regulatory T-cell Targets and Develop Unique Anti-Suppressor-Based Immunotherapies". Pa 2020-06-11
Genmab A/S. (6/10/20). "Press Release: Genmab and AbbVie Announce Broad Oncology Collaboration". Copenhagen & North Chicago, IL. 2020-06-10
Bioqube Ventures. (6/10/20). "Press Release: Bioqube Ventures Launches Bioqube Factory Fund I". Hasselt/Brussels. 2020-06-10
Sofinnova Partners. (6/10/20). "Press Release: Protera Closes $5.6M Series A Financing led by Sofinnova Partners". Santiago & Paris. 2020-06-10
Merck KGaA. (6/10/20). "Press Release: Merck and 10x Genomics Launch Powerful New Option for CRISPR Research". Darmstadt. 2020-06-10
iTeos Therapeutics Inc.. (6/9/20). "Press Release: iTeos Therapeutics Strengthens Leadership Team. Matthew Gall Joins as Chief Financial Officer". Cambridge, MA & Gosselies. 2020-06-09
Evox Therapeutics Ltd.. (6/9/20). "Press Release: Evox Therapeutics Announces a Multi-target RNA Interference and Antisense Research Collaboration and License Agreement with Lilly". 2020-06-09
AiCuris Anti-infective Cures GmbH. (6/9/20). "Press Release: Royalty Pharma Acquires Partial Royalty Interest on Prevymis (Letermovir) from AiCuris Anti-infective Cures GmbH". New York, NY & Wuppertal. 2020-06-09
C2i Genomics, Inc.. (6/9/20). "Press Release: C2i Genomics Raises $12 Million in Series A Funding". New York, NY. 2020-06-09
Boehringer Ingelheim. (6/8/20). "Press Release: New Consortium EUbOPEN Will Provide Tools to Unlock Disease Biology. 66 Million Euros to Generate Open-access Chemical Tools". Frankfurt & Ingelheim. 2020-06-08
Teneobio, Inc.. (6/8/20). "Press Release: Teneobio Enters a Research Collaboration and Licensing Agreement to Develop Next Generation Engineered Cell Therapies with Intellia Therapeutics". Newark, CA. 2020-06-08
Arix Bioscience plc. (6/8/20). "Press Release: Arix Announces Strategic and Operational Update. Christian Schetter Assuming Managing Director Role". London. 2020-06-08
Calliditas Therapeutics AB. (6/5/20). "Press Release: Calliditas Therapeutics Prices Its Initial Public Offering on The Nasdaq Global Select Market in the United States". 2020-06-05
Atlas Venture. (6/5/20). "Press Release: Atlas Venture Announces $400 Million Fund XII and Expansion of Partnership". Cambridge, MA. 2020-06-05
Mobilion Systems, Inc.. (6/4/20). "Press Release: Mobilion Systems Unveils Novel SLIM-based Ion Mobility Product at Virtual ASMS Conference 2020". Chadds Ford, PA. 2020-06-04
GHO Capital Partners LLP. (6/3/20). "Press Release: GHO Capital Acquires X-Chem, a Leading Drug Discovery Service Provider". London. 2020-06-03
Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS". Naarden & Herzliya. 2020-06-03
Twist Bioscience Corporation. (6/3/20). "Press Release: Twist Bioscience Announces Proposed Public Offering of Common Stock". South San Francisco, CA. 2020-06-03
Novo Holdings A/S. (6/3/20). "Press Release: Novo Ventures Leads US$55m Series B Investment in NodThera". Copenhagen. 2020-06-03
Twist Bioscience Corporation. (6/3/20). "Press Release: Twist Bioscience Announces Pricing of a $100 Million Public Offering of Common Stock". South San Francisco, CA. 2020-06-03
Eppendorf AG. (6/2/20). "Press Release: Supervisory Board Appoints New Chief Financial Officer. Axel Jaeger Becomes New Chief Financial Officer of Eppendorf AG". Hamburg. 2020-06-02
1 2 3 ... 117 118 119  next pagenext page



Advertisement

Picture [iito] Männer Ballett 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [iito] Made Without Love 650x80px

» top